CG
GSK icon

Cutler Group’s GSK GSK Stock Holding History

Cutler Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$10K Sell
249
-10,622
-98% -$438K ﹤0.01% 1273
2023
Q4 		$402K Sell
10,871
-2,934
-21% -$105K 0.04% 491
2023
Q3 		$500K Buy
13,805
+1,970
+17% +$69.9K 0.05% 423
2023
Q2 		$421K Sell
11,835
-3,491
-23% -$125K 0.06% 373
2023
Q1 		$545K Buy
15,326
+3,361
+28% +$118K 0.06% 332
2022
Q4 		$420K Buy
11,965
+7,243
+153% +$241K 0.04% 503
2022
Q3 		$138K Buy
4,722
+34
+0.7% +$1.29K 0.01% 1183
2022
Q2 		$255K Buy
+4,688
New +$259K 0.02% 869
2022
Q1 		– Sell
-8,280
Closed -$450K – 5590
2021
Q4 		$456K Sell
8,280
-6,402
-44% -$333K 0.02% 796
2021
Q3 		$701K Buy
14,682
+13,880
+1,731% +$697K 0.03% 618
2021
Q2 		$39K Buy
+802
New +$38.5K ﹤0.01% 2700
2019
Q2 		– Sell
-106
Closed -$5K – 4449
2019
Q1 		$5K Buy
+106
New +$5.3K ﹤0.01% 2906
2017
Q1 		– Sell
-480
Closed -$24.4K – 6665
2016
Q4 		$23K Sell
480
-1,600
-77% -$79K ﹤0.01% 3315
2016
Q3 		$112K Sell
2,080
-560
-21% -$30.7K 0.01% 1709
2016
Q2 		$143K Buy
2,640
+2,160
+450% +$114K 0.01% 1374
2016
Q1 		$24K Sell
480
-3,600
-88% -$179K ﹤0.01% 3092
2015
Q4 		$205K Buy
+4,080
New +$208K 0.01% 1170

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's GSK Position: Q1 2024 in Review

Cutler Group reduced its GSK (GSK) stake by 98% in Q1 2024, selling an estimated $438K and leaving 249 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Cutler Group first reported a position in GSK in Q4 2015 and has held it in 17 quarters since. The position peaked at $701K in Q3 2021. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • Cutler Group held 249 shares of GSK worth $10K as of Q1 2024.
  • Cutler Group sold 10,622 GSK shares in Q1 2024, an estimated $438K.
  • GSK made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1273 holding.
  • Cutler Group first reported a position in GSK in Q4 2015 and has held it in 17 quarters since.
  • Cutler Group's GSK position peaked at $701K in Q3 2021.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.